|
Effects of Low-Sodium Salt on Death, HF Hospitalization/ Emergency Department Visits and Quality of Life in HF Patients
RECRUITINGN/ASponsored by Heart Health Research Center
Actively Recruiting
PhaseN/A
SponsorHeart Health Research Center
Started2025-04-03
Est. completion2027-04-30
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06764225
Summary
This study aims to investigate whether using a low-sodium substitute salt can help improve outcomes for patients with heart failure. Specifically, it will examine if the low-sodium substitute salt can reduce death rates, hospital readmissions, and emergency visits, as well as improve the quality of life for these patients.
Eligibility
Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Aged between 18 and 75 years; 2. Hospitalized due to heart failure in the past year; 3. NYHA functional class II-III; 4. Echocardiographic evidence of LVEF \< 40% within the past 6 months; 5. Receiving guideline-directed medical therapy for heart failure; 6. Stable heart failure status, defined as heart failure stability for more than 4 weeks, with no increase in diuretic dose within the past 4 weeks; 7. Having a primary caregiver and frequently dining together at home; 8. Consuming commercially processed food no more than once a week; 9. Providing written informed consent. Exclusion Criteria: 1. End-stage heart failure; 2. Hospitalization due to cardiovascular causes within the past month; 3. Uncorrected hyponatremia (Na \< 130 mmol/L); 4. Dialysis-dependent patients, or eGFR \< 20 mL/min/1.73m²; 5. Uncontrolled hyperglycemia, with fasting blood glucose \> 16 mmol/L; 6. Malignant cancer patients with a life expectancy of less than 1 year; 7. Conditions that, in the investigator's opinion, may interfere with adherence to the protocol, such as habitual reliance on takeout meals or dining at company cafeterias; 8. Planned hospitalization during the study period; 9. Unexplained weight loss greater than 5 kg in the past year; 10. The subject or family members have concerns about using the salt substitute in this study, or are planning for pregnancy, pregnant, or breastfeeding; 11. Another family member is already participating in this study; 12. The subject or family members are participating in other interventional clinical trials.
Conditions3
Dietary Sodium IntakeHeart DiseaseHeart Failure
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorHeart Health Research Center
Started2025-04-03
Est. completion2027-04-30
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06764225